Prednisone and Ebrantil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prednisone (prednisone) and Ebrantil (urapidil). Common drug interactions include pyrexia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Prednisone and Ebrantil. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,820 Prednisone users. Check the latest studies of Prednisone.

What is Ebrantil?

Ebrantil has active ingredients of urapidil. eHealthMe is studying from 1,656 Ebrantil users. Check the latest studies of Ebrantil.



On Nov, 26, 2025

18 people who take Prednisone and Ebrantil together, and have interactions are studied.

Prednisone and Ebrantil drug interactions.

What are the common drug interactions of Prednisone and Ebrantil, by gender? *:

female:

  1. Pyrexia (fever)
  2. Cough
  3. Abscess (pus)
  4. Enterocolitis bacterial
  5. Erysipelas (bacterial skin infection)
  6. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Intervertebral discitis (infection in the intervertebral disc space)
  9. Respiratory tract infection
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

male:

  1. Pneumonia
  2. Abdominal hernia
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Ureteric stenosis (abnormal narrowing or contraction of a duct or canal)
  5. Laryngitis bacterial (inflammation of the larynx caused by a bacterial infection)
  6. Laryngitis fungal (inflammation of the larynx due to fungal infection)
  7. Oesophageal candidiasis (fungal infection of oesophagus)
  8. Wound dehiscence (a surgical incision reopens either internally or externally)
  9. Infection in an immunocompromised host
  10. Suture rupture

What are the common drug interactions of Prednisone and Ebrantil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Pyrexia (fever)
  2. Cough
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Respiratory tract infection
  6. Cardiac failure congestive
  7. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Diarrhoea
  10. Fatigue (feeling of tiredness)

60+:

  1. Pneumonia
  2. Abdominal hernia
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Ureteric stenosis (abnormal narrowing or contraction of a duct or canal)
  5. Oesophageal candidiasis (fungal infection of oesophagus)
  6. Laryngitis bacterial (inflammation of the larynx caused by a bacterial infection)
  7. Laryngitis fungal (inflammation of the larynx due to fungal infection)
  8. Wound dehiscence (a surgical incision reopens either internally or externally)
  9. Infection in an immunocompromised host
  10. Suture rupture

What are the existing conditions these people have? *

  1. High Blood Pressure: 5 people, 27.78%
  2. Heart Disease: 3 people, 16.67%
  3. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 16.67%
  4. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 5.56%
  5. Prostate Cancer: 1 person, 5.56%
  6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.56%
  7. Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and Ebrantil?

- Personalize this study to your gender, age, symptoms and drugs (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prednisone and Ebrantil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ebrantil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prednisone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ebrantil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on prednisone and urapidil (the active ingredients of Prednisone and Ebrantil, respectively), and Prednisone and Ebrantil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: